Optimizing and assessing staff exposure during 177Lu-DOTATATE PRRT

被引：0
|
作者：
Ben Reguiga, M. [1 ]
机构：
[1] Beaujon Hosp, APHP, Clichy, France
来源：
JOURNAL OF NUCLEAR MEDICINE | 2015年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
7
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Red Bone Marrow Dosimetry and Haematotoxicity in 177Lu-DOTATATE PRRT
    Tshori, S.
    Glasberg, S.
    Luder, D.
    Krausz, Y.
    Gross, D.
    Schwartz, A.
    Freedman, N.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S775 - S776
  • [2] Influence of pretreatment with everolimus or sunitinib on the subacute hematotoxicity of 177Lu-DOTATATE PRRT
    Medaer, Eva
    Verslype, Chris
    Van Cutsem, Eric
    Dekervel, Jeroen
    Clement, Paul M.
    Nackaerts, Kristiaan
    Laenen, Annouschka
    Gheysens, Olivier
    Goffin, Karolien
    Jentjens, Sander
    Van Laere, Koen
    Deroose, Christophe M.
    [J]. ACTA ONCOLOGICA, 2020, 59 (06) : 644 - 651
  • [3] 177Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor
    Parghane, Rahul, V
    Basu, Sandip
    [J]. CLINICAL NUCLEAR MEDICINE, 2022, 47 (10) : 874 - 875
  • [4] Influence of Pretreatment with Everolimus and/or Sunitinib on the Acute Hematotoxicity of 177Lu-DOTATATE PRRT
    Medaer, E.
    Verslype, C.
    Van Cutsem, E.
    Dekervel, J.
    Clement, P.
    Nackaerts, K.
    Gheysens, O.
    Goffin, K.
    Jentjens, S.
    Van Laere, K.
    Deroose, C. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S89 - S90
  • [5] Liver Steatosis Secondary to PRRT With 177Lu-DOTATATE An Unknown Adverse Effect
    de Lima, Beatriz Matheos
    de Carvalho, Juliana Ribeiro
    Gaspar, Priscilla Romano
    Pujatti, Priscilla Brunelli
    Goncalves, Rinaldo
    [J]. CLINICAL NUCLEAR MEDICINE, 2020, 45 (05) : 374 - 376
  • [6] Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE; dosimetric findings
    Mok, S.
    Tay, Y.
    Ng, D.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S532 - S532
  • [7] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Christian Mair
    Boris Warwitz
    Katharina Fink
    Lorenza Scarpa
    Bernhard Nilica
    Johanna Maffey-Steffan
    Sabine Buxbaum
    Irene J. Virgolini
    [J]. Annals of Nuclear Medicine, 2018, 32 : 499 - 502
  • [8] Radiation exposure after 177Lu-DOTATATE and 177Lu-PSMA-617 therapy
    Mair, Christian
    Warwitz, Boris
    Fink, Katharina
    Scarpa, Lorenza
    Nilica, Bernhard
    Maffey-Steffan, Johanna
    Buxbaum, Sabine
    Virgolini, Irene J.
    [J]. ANNALS OF NUCLEAR MEDICINE, 2018, 32 (07) : 499 - 502
  • [9] A Phase II Trial of Dose Escalation in 177Lu-DOTATATE PRRT - the Need for Dosimetry
    Sundlov, A.
    Svensson, J.
    Gleisner, K. Sjogreen
    Ljungberg, M.
    Bernhardt, P.
    Hindorf, C.
    Mortensen, N.
    Morin, K.
    Hermann, R.
    Wangberg, B.
    Ohlsson, T.
    Forssell-Aronsson, E.
    Tennvall, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S225 - S225
  • [10] Esthesioneuroblastoma (Olfactory Neuroblastoma) Treated With 111In-Octreotide and 177Lu-DOTATATE PRRT
    Makis, William
    McCann, Karey
    McEwan, Alexander J. B.
    [J]. CLINICAL NUCLEAR MEDICINE, 2015, 40 (04) : 317 - 321
12345